Clinical Trial Update: Safety and Efficacy of Tocotrienols in Post-CABG Atrial Fibrillation [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating safety and efficacy of tocotrienols for post-CABG atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Tocotrienols (tocotrienols)

Snippet

Sponsor: Monash University Malaysia | Conditions: Atrial Fibrillation | Phase 2, Phase 3 | Status: COMPLETED